A Randomized Study of BMS-986012 in Combination with Carboplatin, Etoposide, and Nivolumab in Participants with Extensive-stage Small Cell Lung Cancer

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2021
This article has no abstract
Epistemonikos ID: 7afe7c968eea6b2d63e167c4440846ff18c6651d
First added on: Apr 11, 2025